Welcome to the Bioasis Technologies Hub On AGORACOM

Free
Message: What will December 2022 bring?

I mistakenly believed that Bioasis was to focus on the acquired Cresence, Phase 2 Ready, Rare Orphan EGF Assets in combination with the Bioasis xB3 platform. I don't see that happening anytime soon with little to no funds in the treasury. Or am I wrong?

https://www.bioasis.us/bioasis-acquires-phase-2-ready-rare-orphan-egf-assets/

 

Koo

Share
New Message
Please login to post a reply